Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5089476
Max Phase: Preclinical
Molecular Formula: C57H79N19O15S
Molecular Weight: 1302.44
Molecule Type: Unknown
Associated Items:
ID: ALA5089476
Max Phase: Preclinical
Molecular Formula: C57H79N19O15S
Molecular Weight: 1302.44
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H]1NC(=O)CNC(=O)CNC(=O)CNC(=O)COCCOCCNC(=O)[C@H](CCCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC1=O
Standard InChI: InChI=1S/C57H79N19O15S/c58-53(59)65-17-3-7-39-49(84)75-41(9-5-19-67-55(62)63)51(86)76-40(8-4-18-66-54(60)61)50(85)74-38(48(83)64-20-21-88-22-23-89-30-47(82)71-28-45(80)69-27-44(79)70-29-46(81)73-39)6-1-2-16-68-56(92)72-31-10-13-35-34(24-31)52(87)91-57(35)36-14-11-32(77)25-42(36)90-43-26-33(78)12-15-37(43)57/h10-15,24-26,38-41,77-78H,1-9,16-23,27-30H2,(H,64,83)(H,69,80)(H,70,79)(H,71,82)(H,73,81)(H,74,85)(H,75,84)(H,76,86)(H4,58,59,65)(H4,60,61,66)(H4,62,63,67)(H2,68,72,92)/t38-,39-,40-,41-/m0/s1
Standard InChI Key: SAUHJPMBBTYCLH-MFDNGWNGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1302.44 | Molecular Weight (Monoisotopic): 1301.5724 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Raju M, Kavarthapu R, Anbazhagan R, Hassan SA, Dufau ML.. (2021) Blockade of GRTH/DDX25 Phosphorylation by Cyclic Peptides Provides an Avenue for Developing a Nonhormonal Male Contraceptive., 64 (19.0): [PMID:34601876] [10.1021/acs.jmedchem.1c01201] |
Source(1):